LIKE US ON FACEBOOK
FOLLOW US ON TWITTER
Posted on September 9, 2014
Mallinckrodt has reported that a Phase 3 efficacy trial of investigational MNK-155 met the study's primary endpoint of improved pain scores vs.
Pain / Anesthetics News From Medical News Today
Want to receive our Journal by mail? Sign up here.